These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22443308)

  • 1. Defining hyperandrogenaemia according to the free androgen index in Chinese women: a cross-sectional study.
    Zhou Z; Ni R; Hong Y; Li Y; Wang Y; Zhao X; Yang D
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):446-52. PubMed ID: 22443308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age.
    Hashemi S; Ramezani Tehrani F; Noroozzadeh M; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():51-5. PubMed ID: 24220143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years.
    Zhou Z; Li R; Qiao J
    Reprod Biomed Online; 2017 Sep; 35(3):331-339. PubMed ID: 28684272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age.
    Zhao X; He Z; Mo Y; Chen X; Chen Y; Yang D
    Eur J Obstet Gynecol Reprod Biol; 2011 Feb; 154(2):187-91. PubMed ID: 21111526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND; Sthaneshwar P; Razali N
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cut-off levels for hyperandrogenemia among Samoan women: An improved methodology for deriving normative data in an obese population.
    Maredia H; Lambert-Messerlian GM; Palomaki GE; Viali S; Hawley NL; McGarvey ST
    Clin Biochem; 2016 Jul; 49(10-11):782-6. PubMed ID: 26908216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
    Yang Y; Ouyang N; Ye Y; Hu Q; Du T; Di N; Xu W; Azziz R; Yang D; Zhao X
    Reprod Biomed Online; 2020 Oct; 41(4):734-742. PubMed ID: 32912651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
    Chanukvadze D; Kristesashvili J
    Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The free androgen index is inaccurate in women when the SHBG concentration is low.
    Keevil BG; Adaway J; Fiers T; Moghetti P; Kaufman JM
    Clin Endocrinol (Oxf); 2018 May; 88(5):706-710. PubMed ID: 29405348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
    Yasmin E; Balen AH; Barth JH
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menstrual irregularity and bone mass in premenopausal women: cross-sectional associations with testosterone and SHBG.
    Wei S; Jones G; Thomson R; Otahal P; Dwyer T; Venn A
    BMC Musculoskelet Disord; 2010 Dec; 11():288. PubMed ID: 21190585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
    J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia.
    Cho LW; Kilpatrick ES; Jayagopal V; Diver MJ; Atkin SL
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):390-4. PubMed ID: 17888022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance.
    Cai J; Wu CH; Zhang Y; Wang YY; Xu WD; Lin TC; Li SX; Wang LH; Zheng J; Sun Y; Liu W; Tao T
    Int J Obes (Lond); 2017 Sep; 41(9):1341-1347. PubMed ID: 28487551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN).
    Sutton-Tyrrell K; Wildman RP; Matthews KA; Chae C; Lasley BL; Brockwell S; Pasternak RC; Lloyd-Jones D; Sowers MF; Torréns JI;
    Circulation; 2005 Mar; 111(10):1242-9. PubMed ID: 15769764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
    Mueller A; Cupisti S; Binder H; Hoffmann I; Kiesewetter F; Beckmann MW; Dittrich R
    Horm Res; 2007; 67(1):35-41. PubMed ID: 17019078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism.
    Al Kindi MK; Al Essry FS; Al Essry FS; Mula-Abed WA
    Oman Med J; 2012 Nov; 27(6):471-4. PubMed ID: 23226817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.